Residual impurities can potentially be introduced into the biopharmaceutical manufacturing process at a variety of stages. Recently, nitrosamines and elemental impurities have been a concern for regulatory agencies. These impurities originate from various raw materials, process chemicals, and manufacturing equipment. Single-use systems (SUS) incorporate a number of plastic components. A key concern related to plastic SUS is potential leachable compounds from contact materials. It’s essential to obtain information on leachables as well as nitrosamines and elemental impurities. This webinar looks into how to evaluate nitrosamine and elemental impurity risk related to SUS and filters.
In this webinar, you will:
Janmeet Anant, Ph.D.
Senior Regulatory Consultant
Janmeet Anant is a senior regulatory consultant, focused on biopharmaceutical manufacturing at MilliporeSigma. Janmeet serves as an executive board member for the Bioprocess Systems Alliance (BPSA) and a member of the Regulatory Governance Team at BioPhorum.
He has more than 20 years of experience, moving through technical application roles for chromatography, filtration, cell culture and, most recently, regulatory consulting. Janmeet has a B.S. in Chemistry and a Ph.D. in Pharmacology.
Emprove® Program Manager
Jessica Shea is the Emprove® program manager responsible for filters, single-Use, and chromatography resin portfolios within MilliporeSigma. Previously, she was responsible for extractables and leachables global support for the BioReliance® validation services. She has more than 14 years of E&L experience, including method validation, designing of custom testing, and interpreting industry and regulatory guidance. Jessica has a B.S. in biochemistry and an MBA.
To continue reading please sign in or create an account.Don't Have An Account?